Reaction Details Report a problem with these data
Target
Kallikrein-1
Ligand
BDBM162669
Substrate
n/a
Meas. Tech.
KLK1 Activity Assay
pH
7.5±n/a
Temperature
310.15±n/a K
IC50
>100000±n/a nM
Comments
extracted
Citation
 Short, KM; Pham, SM; Williams, DC; Kita, DB Multisubstituted aromatic compounds as serine protease inhibitors US Patent  US9687479 Publication Date 6/27/2017 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM162669
Synonyms:
US9687479, 149 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(4-methyloxan-4-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one
Type:
Small Organic Molecule
Emp. Form.:
C23H27ClN4O4S
Mol. Mass.:
491.003
SMILES:
COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)C2(C)CCOCC2)c1=O
Structure:
Search PDB for entries with ligand similarity: